Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Innovative Technique for Coronary Angiography in Marginal Donors
Published on: July 12, 2024
The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic
Myung-Jin Choi1, Jong-Woo Yoon1, Sang-Jin Han2
1Department of Internal Medicine, College of Medicine, Hallym University, Republic of Korea; Hallym University Kidney Research Institute, Republic of Korea.
Insights
Simultaneous hemofiltration offers comparable early renal protection against contrast-induced nephropathy (CIN) and superior late-stage protection in chronic kidney disease (CKD) patients undergoing coronary angiography, at a significantly lower cost than periprocedural hemofiltration.
Area of Science:
- Nephrology
- Cardiology
- Intensive Care Medicine
Background:
- Contrast-induced nephropathy (CIN) is a risk for chronic kidney disease (CKD) patients undergoing coronary angiography.
- Periprocedural hemofiltration (PHF) prevents CIN but overuses resources and can lead to persistent renal injury.
- Simultaneous hemofiltration (SHF) during angiography offers a more resource-efficient alternative with immediate renal protection.
Purpose of the Study:
- To compare the efficacy and cost-effectiveness of simultaneous hemofiltration versus periprocedural hemofiltration in preventing CIN in CKD patients undergoing coronary angiography.
Main Methods:
- A randomized controlled trial involving 68 CKD patients undergoing coronary angiography.
- Patients were randomized to receive either periprocedural hemofiltration (n=23) or simultaneous hemofiltration (n=45).
- Renal function was assessed by serum creatinine levels and CIN incidence at multiple time points post-procedure.
Main Results:
- Both groups showed similar early CIN rates on day 3 (17.4% vs. 15.6%, p=0.846).
- Simultaneous hemofiltration demonstrated significantly lower late-stage CIN rates on days 5-30 (6.7% vs. 30.4%, p=0.009).
- Serum creatinine levels increased in the periprocedural group post-discharge, unlike the simultaneous group. SHF was significantly less costly ($504±40 vs. $1066±83, p<0.001).
Conclusions:
- Simultaneous hemofiltration provides equivalent early and superior late-stage renal protection against CIN compared to periprocedural hemofiltration.
- SHF is a more cost-effective strategy for preventing CIN in CKD patients undergoing coronary angiography.
- SHF mitigates persistent renal injury observed with PHF.
Background:
Periprocedural (6 h pre- and 24 h post-angiography) hemofiltration appears to effectively prevent contrast-induced nephropathy (CIN) in chronic kidney disease (CKD) patients undergoing coronary angiography. However, this procedure over-uses medical resources, and the cessation of hemofiltration during coronary angiography results in persistent renal injury. In comparison, simultaneous hemofiltration performed only during coronary angiography requires fewer medical resources and can provide instantaneous protection against CIN.
Methods:
Sixty-eight CKD patients (serum creatinine, 2.51±1.15 mg/dL) undergoing coronary angiography were randomized in a 1:2 ratio to receive either periprocedural (n=23) or simultaneous (n=45) hemofiltration. The expected CIN rate was similar for the two groups (41.3% versus 40.0%, p=0.769).
Results:
On day 3 after contrast exposure, four and seven patients in the periprocedural and simultaneous groups, respectively experienced CIN (17.4% versus 15.6%, p=0.846). On days 5-30, seven and three patients in the periprocedural and simultaneous groups, respectively experienced CIN (30.4% versus 6.7%, p=0.009). The serum creatinine levels of patients in the periprocedural group transiently decreased on day 1 and persistently increased during days 5-30 compared with the simultaneous group. This difference between the two groups in terms of creatinine levels over time was statistically significant (F statistic=6.830; p=0.001, by ANCOVA). The cost of hemofiltration was doubled in the periprocedural group ($1066±83 versus $504±40, p<0.001).
Conclusions:
Simultaneous hemofiltration provide equal early (day 3) and better late-stage (days 5-30) renal protection against CIN at a significantly lower cost compared with periprocedural hemofiltration.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
06:02Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hemodialysis II: Procedure and Complications